Background & Aims Accurate estimates for the contemporary burden of chronic liver disease
(CLD) are vital for setting clinical, research, and policy priorities. We aimed to review the …

Introduction Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third-
leading cause of cancer-related mortality in the world. Areas covered This review will …

The major risk factors for hepatocellular carcinoma (HCC) in contemporary clinical practice
are becoming increasingly related to sustained virological response after hepatitis C …

Hepatocellular cancer (HCC) is the fourth leading cause of cancer-related deaths worldwide
and the fastest growing cause of cancer deaths in the United States. The overall prognosis …

Hepatocellular Carcinoma (HCC) is a highly aggressive cancer with mortality running
parallel to its incidence and has limited therapeutic options. Chronic liver inflammation and …

Background & Aims Recently, the PAGE-B score and Toronto HCC risk index (THRI) have
been developed to predict the risk of hepatocellular carcinoma (HCC) in Caucasian patients …

Conclusions: HCC incidence among patients with cirrhosis was lower than previously
reported. HCC risk was variable across etiologies, with higher risk in patients with HCV …

Liver cancer, of which hepatocellular carcinoma (HCC) is the dominant variety, represents
the fourth leading cause of cancer deaths worldwide. The geographic map of the incidence …

Hepatocellular carcinoma (HCC) is an epidemic burden and remains highly prevalent
worldwide. The significant mortality rates of HCC are largely due to the tendency of late …

Chronic hepatitis B virus (HBV) infection is a major risk factor for hepatocellular carcinoma
(HCC), and surveillance is recommended for patients without cirrhosis when risk exceeds an …